Expert Video - What are erythropoietin-stimulating agents (ESAs)?
MDS experts, Dr Alan List and Dr David Sallman, provide an overview of the use of erythropoietin-stimulating agents (ESAs) for myelodysplastic syndromes (MDS). ESAs stimulate the bone marrow to help make red blood cells. They describe how ESAs are given, how often they are used, and how long the benefits typically last.
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about MDS which will help other patients, caregivers and families.
Other Modules:
Animation - Management and Treatment of MDS
Slide Show - Management and Treatment of MDS
1.
What are the treatment options for MDS?
2.
How is lower-risk MDS treated?
3.
How is higher-risk MDS treated?
4.
What is supportive care for MDS?
5.
Are vitamin supplements beneficial for MDS treatment?
6.
What are erythropoietin-stimulating agents (ESAs)?
7.
What is cytotoxic chemotherapy and when is it used for MDS?
8.
What is lenalidomide and when is it used for MDS?
9.
What are hypomethylating agents and when are they used for MDS?
10.
How long will MDS treatment be given?
11.
What is immunosuppressive therapy and when is it used for MDS?
12.
What other options are there if first-line MDS treatment doesn’t work?
13.
David's story: How was your MDS initially treated?
